Tus kws kho mob
QP88-23 MCG Care Guidelines Transparency Tool Available via Availity Essentials by October 27, 2023
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 25, 2023
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 1201 - 1210 ntawm 4303
Kev Yuav Khoom thiab Kev Kawm Paub
2023-dhs-website-summary-v.1.pdf
Tus kws kho mob
QP55R1-23 Change in Processing for Replacement Claims
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 11, 2023
Tus kws kho mob
QP80-23 Blue Cross Response to Medical Oncology Drug Shortage of Cisplatin and Carboplatin
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 11, 2023
Tus kws kho mob
QP81-23 Update: Medical Drug Update for Tofersen (Qalsody), Delandistrogene Moxeparvovec (Elevidys), and Donislecel (Lantidra)
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 11, 2023
Tus kws kho mob
QP82-23 Commercial Pharmacy Benefit Exclusion for Beyfortus™, Daxxify®, Izervay™, and Veopoz™
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 11, 2023
Tus kws kho mob
QP83-23 Commercial Pharmacy Benefit Exclusion for Budesonide-Formoterol Aerosol Inhaler and Tiotropium Bromide Inhalation Capsule
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 11, 2023
Tus kws kho mob
QP84-23 Commercial Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective December 1, 2023
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 11, 2023
Tus kws kho mob
QP85-23 MHCP Pharmacy Benefit Exclusion for Beyfortus™, Daxxify®, Elrexfio™, Izervay™, Talvey™, and Veopoz™
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 11, 2023